| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/18/2010 | CA2761393A1 Ttk peptides and vaccines including the same |
| 11/18/2010 | CA2759836A1 Humanized axl antibodies |
| 11/17/2010 | EP2251693A1 Method and kit for detection of anti-avibacterium paragallinarum antibody |
| 11/17/2010 | EP2251424A1 Antigenic neisserial peptides |
| 11/17/2010 | EP2251357A1 Camelidae single domain antibodies VHH directed against epidermal growth factor receptor and uses therefor |
| 11/17/2010 | EP2251356A2 Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
| 11/17/2010 | EP2251355A1 Treatment with anti-VEGF antibodies |
| 11/17/2010 | EP2251354A1 Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-r prothrombin activation peptide fragment f2 (des-r f2) in a serum |
| 11/17/2010 | EP2251353A1 Homogeneous preparations of IL-28 and IL-29 |
| 11/17/2010 | EP2251352A1 Homogeneous preparations of IL-28 and IL-29 |
| 11/17/2010 | EP2251037A1 KIM-1 antibodies for treatment of TH1/TH2-mediated conditions |
| 11/17/2010 | EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| 11/17/2010 | EP2250201A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 11/17/2010 | EP2250200A2 Il-17ra-il-17rb antagonists and uses thereof |
| 11/17/2010 | EP2250199A1 Engineered anti-tslpr antibodies |
| 11/17/2010 | EP2250198A1 A humanized high affinity recombinant antibody against hepatitis b surface antigen |
| 11/17/2010 | EP2250197A1 Binding protein and epitope-blocking elisa for the universal detection of h5-subtype influenza viruses |
| 11/17/2010 | EP2250196A2 Engineered antibody constant domain molecules |
| 11/17/2010 | EP2249661A2 Products and methods to prevent infection |
| 11/17/2010 | EP1565489B1 Internalizing antibodies specific for the RAAG10 cell surface target |
| 11/17/2010 | EP1545597B1 Immunostimulatory compositions and methods of stimulating an immune response |
| 11/17/2010 | EP1534830B1 In vitro peptide expression libraray |
| 11/17/2010 | EP1506295B1 Muteins of placental growth factor type 1, preparation method and application thereof |
| 11/17/2010 | EP1362093B1 Rapid production of monoclonal antibodies |
| 11/17/2010 | EP1204682B1 Compositions and methods for the treatment of tumors |
| 11/17/2010 | EP1159003B1 Anti-tnf alpha antibodies in therapy of steroid resistant asthma |
| 11/17/2010 | CN201634611U Yolk acidification and lamination antibody extracting tank |
| 11/17/2010 | CN1871359B Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 11/17/2010 | CN101889082A Method and kits for dissociating Fcgamma-receptor-IgG complexes and for igg purification and detection |
| 11/17/2010 | CN101889026A Il-23 antibodies |
| 11/17/2010 | CN101889025A Antibody purification by cation exchange chromatography |
| 11/17/2010 | CN101889021A Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 11/17/2010 | CN101888866A Needle-free delivery device for therapeutic proteins based on single antigen-binding domains such as nanobodies tm |
| 11/17/2010 | CN101888856A Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 11/17/2010 | CN101886082A Method for producing humanized monoclonal antibody using animal mammary gland bioreactor |
| 11/17/2010 | CN101885775A Preparation and enzyme-linked immunosorbent assay method for heavy metal mercury polyclonal antibody |
| 11/17/2010 | CN101885774A Methandienone monoclonal antibody, preparation method and application thereof |
| 11/17/2010 | CN101885773A Icariin monoclonal antibody and preparation method and application thereof |
| 11/17/2010 | CN101885772A Baicalin monoclonal antibody as well as preparation method and application thereof |
| 11/17/2010 | CN101885771A Preparation and applications of monoclonal antibody and polyclonal antibody of human tissue factor pathway inhibitor-2 |
| 11/17/2010 | CN101885770A Fully human antibody capable of specifically bonding CD15 and use thereof |
| 11/17/2010 | CN101885769A Fully human antibody capable of specifically bonding CD4 and use thereof |
| 11/17/2010 | CN101885766A Novel neurotrophic factor, preparation thereof and application thereof |
| 11/17/2010 | CN101885757A Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies |
| 11/17/2010 | CN101884789A Ctgf as target for the therapy of diabetic nephropathy |
| 11/17/2010 | CN101307109B Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use |
| 11/17/2010 | CN101052412B Amebiasis subunit vaccine |
| 11/17/2010 | CN101035809B Humanized anti-tag-72 monoclonal antibodies |
| 11/16/2010 | US7834258 Dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same |
| 11/16/2010 | US7834165 Nucleic acid sequence and vectors encoding chimeric human T1R3 taste receptor |
| 11/16/2010 | US7834158 Mutated immunoglobulin-binding protein |
| 11/16/2010 | US7834157 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 11/16/2010 | US7834156 Monoclonal antibody comprising cytotoxic fusion for use in treatment of cell proliferative disorers |
| 11/16/2010 | US7834155 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 11/16/2010 | US7834154 Angiogenesis inhibition |
| 11/16/2010 | US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 11/16/2010 | US7833972 Proteins and use thereof |
| 11/16/2010 | US7833786 Anti-IL-6 antibodies, compositions, methods and uses |
| 11/16/2010 | US7833751 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 11/16/2010 | US7833733 Methods for detecting and treating cancer |
| 11/16/2010 | US7833731 A protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance; kits |
| 11/16/2010 | US7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes |
| 11/16/2010 | US7833726 monoclonal antibody which has specific reactivity to an antigenic determinant site produced by reacting ADAMTS13 with VWF that is a substrate; Thrombotic thrombocytopenic purpura |
| 11/16/2010 | US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 11/16/2010 | US7833703 Method for the construction of randomized gene sequence libraries in cells |
| 11/16/2010 | US7833531 means of delivering the GLP-1 peptide in a sustained manner; obesity related disorders |
| 11/16/2010 | US7833530 Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies |
| 11/16/2010 | US7833528 Drug delivery where chemotherapeutic drug is converted to an active drug by a target-tissue-localized complex that comprises an enzyme formed by premixing bispecific monoclonal antibody or bispecific antibody fragment with a hapten-enzyme covalent conjugate |
| 11/16/2010 | US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 11/16/2010 | US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon |
| 11/16/2010 | US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 11/16/2010 | CA2422622C Novel baff-r nucleic acids and polypeptides |
| 11/16/2010 | CA2215529C Carbohydrate-based vaccine and diagnostic reagent for trichinosis |
| 11/11/2010 | WO2010129959A1 Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna germline antibodies |
| 11/11/2010 | WO2010129917A2 Anti-cd100 antibodies and methods for using the same |
| 11/11/2010 | WO2010129904A1 Humanized anti-egfl7 antibodies and methods using same |
| 11/11/2010 | WO2010129752A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both |
| 11/11/2010 | WO2010129713A2 Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject |
| 11/11/2010 | WO2010129541A1 Emulsion selection of antibodies |
| 11/11/2010 | WO2010129270A2 Profiling fragments of elastic fibers and microfibrils as biomarkers for disease |
| 11/11/2010 | WO2010129033A2 Modified antibodies for passive immunotherapy |
| 11/11/2010 | WO2010128657A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
| 11/11/2010 | WO2010128398A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability |
| 11/11/2010 | WO2010128265A2 Use of igg1 immunoglobulins and/or ligands of the cd32 receptor for treating inflammatory diseases and incidents via the mucosa |
| 11/11/2010 | WO2010128223A1 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases |
| 11/11/2010 | WO2010128193A1 Method for the diagnosis, prognosis and/or treatment of systemic lupus erythematosus |
| 11/11/2010 | WO2010128158A1 Diagnostic biomarkers for fibrotic disorders |
| 11/11/2010 | WO2010128145A1 Method of controlling o-linked glycosylation of antibodies |
| 11/11/2010 | WO2010128143A1 Method of controlling o-linked glycosylation of antibodies |
| 11/11/2010 | WO2010128053A1 Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases |
| 11/11/2010 | WO2010128035A1 Treatment for multiple sclerosis |
| 11/11/2010 | WO2010127784A1 Polypeptide derived from enterococcus and its use for vaccination |
| 11/11/2010 | WO2010127642A1 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof |
| 11/11/2010 | WO2010127400A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb) |
| 11/11/2010 | WO2010089126A3 Immunoglobulin glycosylation pattern analysis |
| 11/11/2010 | WO2009142773A9 Multivalent fibronectin based scaffold domain proteins |
| 11/11/2010 | US20100287664 Genes for enhancing resistance to magnaporthe oryzae and uses thereof |
| 11/11/2010 | US20100287637 Methods of blocking tissue destruction by autoreactive t cells |
| 11/11/2010 | US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations |
| 11/11/2010 | US20100287632 Rapid Production of Monoclonal Antibodies |